Literature DB >> 14254250

PH OPTIMA IN IMMUNE HEMOLYSIS: A COMPARISON BETWEEN GUINEA PIG AND HUMAN COMPLEMENT.

S YACHNIN, J M RUTHENBERG.   

Abstract

Entities:  

Keywords:  COMPLEMENT; EXPERIMENTAL LAB STUDY; GUINEA PIGS; HEMOLYSIS; HYDROGEN-ION CONCENTRATION; IMMUNOCHEMISTRY

Mesh：

Substances：

Year:  1965        PMID： 14254250      PMCID： PMC442027          DOI： 10.1172/JCI105121

Source DB:  PubMed          Journal:  J Clin Invest        ISSN： 0021-9738            Impact factor:   14.808


× No keyword cloud information.
  18 in total

1.  BIOLOGIC PROPERTIES OF POLYNUCLEOTIDES. I. THE ANTICOMPLEMENTARY ACTIVITY OF POLYNUCLEOTIDES.

Authors:  S YACHNIN
Journal:  J Clin Invest       Date:  1963-12       Impact factor: 14.808

2.  Contribution of serum and cellular factors in host defense reactions. I. Serumfactors in host resistanc.

Authors:  K F AUSTEN; Z A COHN
Journal:  N Engl J Med       Date:  1963-04-25       Impact factor: 91.245

3.  Activity of CT in rabbit antisheep hemolysin.

Authors:  L L DELOOZE; A RANSBY; M A LEON
Journal:  Proc Soc Exp Biol Med       Date:  1962-02

4.  Studies of aggregated gamma-globulin. I. Sedimentation, electrophoretic and anticomplementary properties.

Authors:  C L CHRISTIAN
Journal:  J Immunol       Date:  1960-01       Impact factor: 5.422

5.  A study of the mechanism of the anticomplementary activity of gamma-globulin.

Authors:  D M MARCUS
Journal:  J Immunol       Date:  1960-03       Impact factor: 5.422

6.  Assay and properties of serum inhibitor of C'l-esterase.

Authors:  L R LEVY; I H LEPOW
Journal:  Proc Soc Exp Biol Med       Date:  1959 Aug-Sep

7.  The properdin system and immunity. IV. The hemolysis of erythrocytes from patients with paroxysmal nocturnal hemoglobinuria.

Authors:  C F HINZ; W S JORDAN; L PILLEMER
Journal:  J Clin Invest       Date:  1956-05       Impact factor: 14.808

8.  Studies on the mechanism of inactivation of human complement by plasmin and by antigen-antibody aggregates. I. The requirement for a factor resembling C'1 and the role of Ca++.

Authors:  I H LEPOW; L WURZ; O D RATNOFF; L PILLEMER
Journal:  J Immunol       Date:  1954-09       Impact factor: 5.422

9.  ISOLATION AND DESCRIPTION OF THE FOURTH COMPONENT OF HUMAN COMPLEMENT.

Authors:  H J MUELLER-EBERHARD; C E BIRO
Journal:  J Exp Med       Date:  1963-09-01       Impact factor: 14.307

10.  COMPONENTS OF GUINEA PIG COMPLEMENT. II. SEPARATION OF SERUM FRACTIONS ESSENTIAL FOR IMMUNE HEMOLYSIS.

Authors:  W D LINSCOTT; K NISHIOKA
Journal:  J Exp Med       Date:  1963-11-01       Impact factor: 14.307
View more
  5 in total

1.  THE HEMOLYSIS OF RED CELLS FROM PATIENTS WITH PAROXYSMAL NOCTURNAL HEMOGLOBINURIA BY PARTIALLY PURIFIED SUB-COMPONENTS OF THE THIRD COMPLEMENT COMPONENT.

Authors:  S YACHNIN
Journal:  J Clin Invest       Date:  1965-09       Impact factor: 14.808

2.  Haemolysis in chicken serum. I. The ionic environment.

Authors:  A E Gabrielsen; R J Pickering; R A Good
Journal:  Immunology       Date:  1973-08       Impact factor: 7.397

3.  A platelet and granulocyte membrane defect in paroxysmal nocturnal hemoglobinuria: usefulness for the detection of platelet antibodies.

Authors:  R H Aster; S E Enright
Journal:  J Clin Invest       Date:  1969-07       Impact factor: 14.808

4.  Detection of complement components on unlysed erythrocytes from acid hemolysis and thrombin test reactions in paroxysmal nocturnal hemoglobinuria.

Authors:  D E Jenkins; W N Christenson; R L Engle
Journal:  J Clin Invest       Date:  1966-05       Impact factor: 14.808

5.  THE INITIATION AND ENHANCEMENT OF HUMAN RED CELL LYSIS BY ACTIVATORS OF THE FIRST COMPONENT OF COMPLEMENT AND BY FIRST COMPONENT ESTERASE; STUDIES USING NORMAL RED CELLS AND RED CELLS FROM PATIENTS WITH PAROXYSMAL NOCTURNAL HEMOGLOBINURIA.

Authors:  S YACHNIN; J M RUTHENBERG
Journal:  J Clin Invest       Date:  1965-04       Impact factor: 14.808
  5 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.